Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2018-1
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2018-1
HYC
FNCL
HAXNP 2018-1 (USD 150m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
BNP
,
CMG
,
CSI
,
GUO
,
...
APAC
Mar 8, 2018
Missing something? Tell us.